临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2014年
10期
1297-1298
,共2页
卡介苗多糖核酸%依匹斯汀%慢性湿疹
卡介苗多糖覈痠%依匹斯汀%慢性濕疹
잡개묘다당핵산%의필사정%만성습진
BCG polysaccharide nucleic acid%Epinastine%Chronic eczema
目的:探讨卡介苗多糖核酸联合依匹斯汀治疗慢性湿疹的临床疗效及不良反应情况。方法116例慢性湿疹病例被随机分为观察组和对照组各58例,观察组肌注卡介苗多糖核酸隔日一次,连续4 w,每日口服依匹斯汀10 mg,联合外用丁酸氢化可的松软膏;对照组每日口服依匹斯汀10 mg联合外用丁酸氢化可的松软膏,涂于患处,每日早晚两次。观察两组患者的治疗效果及不良反应情况。结果观察组治愈26例、显效26例,有效6例,总有效率100%;对照组治愈13例、显效20例、有效20例,总有效率91.4%,差异具有统计学意义(P<0.05)。观察组复发3例(5.17%),对照组复发13例(22.4%),差异具有统计学意义(P<0.05)。两组患者均未观察到严重的不良反应。结论卡介苗多糖核酸联合依匹斯汀治疗慢性湿疹疗效确切,不良反应较轻,能显著降低患者的复发率。
目的:探討卡介苗多糖覈痠聯閤依匹斯汀治療慢性濕疹的臨床療效及不良反應情況。方法116例慢性濕疹病例被隨機分為觀察組和對照組各58例,觀察組肌註卡介苗多糖覈痠隔日一次,連續4 w,每日口服依匹斯汀10 mg,聯閤外用丁痠氫化可的鬆軟膏;對照組每日口服依匹斯汀10 mg聯閤外用丁痠氫化可的鬆軟膏,塗于患處,每日早晚兩次。觀察兩組患者的治療效果及不良反應情況。結果觀察組治愈26例、顯效26例,有效6例,總有效率100%;對照組治愈13例、顯效20例、有效20例,總有效率91.4%,差異具有統計學意義(P<0.05)。觀察組複髮3例(5.17%),對照組複髮13例(22.4%),差異具有統計學意義(P<0.05)。兩組患者均未觀察到嚴重的不良反應。結論卡介苗多糖覈痠聯閤依匹斯汀治療慢性濕疹療效確切,不良反應較輕,能顯著降低患者的複髮率。
목적:탐토잡개묘다당핵산연합의필사정치료만성습진적림상료효급불량반응정황。방법116례만성습진병례피수궤분위관찰조화대조조각58례,관찰조기주잡개묘다당핵산격일일차,련속4 w,매일구복의필사정10 mg,연합외용정산경화가적송연고;대조조매일구복의필사정10 mg연합외용정산경화가적송연고,도우환처,매일조만량차。관찰량조환자적치료효과급불량반응정황。결과관찰조치유26례、현효26례,유효6례,총유효솔100%;대조조치유13례、현효20례、유효20례,총유효솔91.4%,차이구유통계학의의(P<0.05)。관찰조복발3례(5.17%),대조조복발13례(22.4%),차이구유통계학의의(P<0.05)。량조환자균미관찰도엄중적불량반응。결론잡개묘다당핵산연합의필사정치료만성습진료효학절,불량반응교경,능현저강저환자적복발솔。
Objective To investigate the clinical efficacy and adverse reactions of BCG polysaccharide nucleic acid in combination with epinastine in the treatment of chronic eczema. Methods 116 cases of patients with chronic eczema were randomly divided into observation group and control group, with 58 cases in each group. The observation group received BCG polysaccharide nucleic acid by intramuscular way once every other day for 4 weeks and taken epinastine 10 mg orally every day combined with topical butyric acid Hydrocorti-sone Ointment. The control group was given daily oral epinastine 10 mg combined with topical butyric acid Hydrocorti-sone Ointment, which was applied to the affected area twice every day. The adverse reactions and therapeutic effect of two groups were compared. Results In the observation group, 26 cases were cured, 26 cases took significant effect, 6 cases took effect, the total efficiency was 100%;in the control group, 13 cases were cured, 20 cases took significant effect, 20 cases took effect, the total effective rate was 91.4%, with statistically significant difference (P <0.05). 3 cases of the observation group relapsed (5.17%), 13 cases of the control group relapsed (22.4%), with statistically significant difference (P<0.05). Serious adverse events in the two groups were not found. Conclusions The effect of BCG polysaccharide nucleic acid combined with epinastine in treating chronic eczema is curative, with fewer adverse reactions, and can significantly reduce the relapse rate.